Good News! Guizhou Tiandi Pharmaceutical Successfully Obtains International Certification for Three Major ISO Management Systems

Guizhou Tiandi Pharmaceutical Co., Ltd. has recently successfully passed the international standard certifications for ISO 9001 Quality Management System, ISO 14001 Environmental Management System, andISO 45001 Occupational Health and Safety Management System. This milestone achievement marks the company’s official alignment with international standardized operational norms, representing a new leap forward in standardized, refined and systematic corporate governance and injecting strong impetus into the company’s sustained high-quality development.

The certification audit was conducted in two phases by the expert team of Beijing Zhongjing Kehuan Quality Certification Co., Ltd. The first-stage audit was carried out from June 29 to July 1, during which the expert team comprehensively reviewed the company’s system documents, management regulations and operational plans, and identified areas for further system improvement. The second-stage on-site audit took place from July 18 to July 22. The audit team conducted in-depth inspections across production workshops, central laboratories, warehousing and logistics departments, administrative offices, staff canteens and other functional areas. Through document review, on-site inspection, staff interviews and process verification, the team performed a full-range and multi-level assessment covering pharmaceutical production quality control, environmental governance, occupational health protection, risk prevention and control, and continuous improvement mechanisms.

The audit experts fully recognized the effective implementation of the three major management systems. They unanimously confirmed that all corporate management activities comply with international standard requirements and that the systems operate stably and effectively, approving the company for all three certifications.

As a well-known local injection pharmaceutical manufacturer, Guizhou Tiandi Pharmaceutical regards product quality as the foundation of its survival, and green development and safe production as the bottom line of sustainable growth. The company has long committed to the integrated management of quality, environment, and occupational health and safety, embedding the three major system standards into the entire process of pharmaceutical research and development, production and manufacturing, quality inspection, and logistical support.

The company’s ISO 9001 quality management system covers procurement, warehousing, logistics, sales and after-sales services. By setting rigorous key control points, the company effectively manages pharmaceutical quality risks, ensures the consistent delivery of reliable medicines and services, and safeguards customer trust. In terms of ISO 14001 environmental management, the company implements energy-saving and emission-reduction initiatives to lower resource consumption, fulfill environmental responsibilities, and build a green brand image. For ISO 45001 occupational health and safety management, systematic risk identification, assessment and hazard rectification are performed to create a safe and healthy workplace and enhance team cohesion.

These standardized systems serve as core tools for optimizing internal management, reducing costs and improving efficiency, as well as indispensable qualifications and competitive advantages for accessing high-end markets and participating in major project tenders.

The three ISO certifications are internationally recognized corporate assessment benchmarks and credibility credentials, acting as an “international passport” for enterprise development. They comprehensively upgrade the company’s operational standardization and market competitiveness from the three core dimensions of quality, safety and environment. Fully endorsing the company’s comprehensive management capabilities by authoritative institutions, the certifications represent a new starting point for future development. They further consolidate internal management foundations, enhance brand credibility, provide solid qualification support for domestic and overseas market expansion and international business cooperation, and facilitate the steady global expansion of the company’s pharmaceutical products.